शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
VIYASHNSEViyash Scientific Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Thu, 20 Nov, 2025 · 18:46 IST

Certified order passed by NCLT Hyderabad Bench

VIYASH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.2%Reaction day
₹239.05
prior close
₹239.40
announcement price
After-mkt
timing
Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-1.5%+1.3% vs market
Pharmaceuticals peers, median of 154sector-0.8%+0.6% vs sector

On the reaction day the stock moved 1.3 pts more than Nifty Microcap 250 and 0.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.5
10m
+0.7
15m
+0.8
30m
+1.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.2-1.5+1.3-0.8+0.6
Next day
-7.2-2.1-5.0-1.5-5.6
2d
-7.2-2.0-5.2-2.0-5.2
3d
-7.6-0.7-6.8-0.7-6.9
4d
-5.3-1.2-4.2-0.9-4.5
5d
-6.0-1.3-4.8-0.7-5.3
1w
-9.5-2.0-7.5-1.1-8.5
15d
-12.3-4.4-7.8-2.5-9.8
1m
-8.6-3.2-5.3-2.0-6.6
2m
-18.6-11.8-6.8-9.0-9.5
3m
-9.0-7.3-1.7-9.0+0.1
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 154Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Viyash Scientific Limited has informed the stock exchange that a certified order has been passed by the National Company Law Tribunal (NCLT), Hyderabad Bench. The company has filed the certified copy of the order with the exchanges. No specific details about the nature, scope, or subject matter of the order have been disclosed in this filing. The filing appears to be a procedural compliance update sharing the existence of the NCLT order. Without the full text of the order, it is unclear whether this relates to insolvency admission, a resolution plan approval, or another corporate matter.

Likely market impact

The limited information makes it difficult to assess the immediate impact on shareholders. Investors should look for the detailed order text or follow-up filings to understand whether this is a routine matter or something materially significant for the company's operations or financial health.